PubRank

M Dechavanne

Author PubWeight™ 71.09‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Acquired protein S deficiency: correlation with advanced disease in HIV-1-infected patients. J Acquir Immune Defic Syndr 1992 1.67
2 Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis. J Clin Invest 1982 1.50
3 Systemic but not renal production of prostacyclin is highly reduced in cyclosporin-treated heart transplant recipients. Am J Cardiol 1993 1.39
4 A simple and efficient method for platelet isolation from their plasma. Thromb Res 1980 1.26
5 Pseudomembranous colitis probably due to rifampicin. Lancet 1980 1.22
6 Rapid purification and partial characterization of human platelet glycoprotein IIIb. Interaction with thrombospondin and its role in platelet aggregation. J Biol Chem 1989 1.18
7 Glycoproteins of platelet membranes from Glanzmann's thrombasthenia. A comparison with normal using carbohydrate-specific or protein-specific labelling techniques and high-resolution two-dimensional gel electrophoresis. Eur J Biochem 1981 1.13
8 Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors. Stroke 1998 1.08
9 Controlled trial of platelet anti-aggregating agents and subcutaneous heparin in prevention of postoperative deep vein thrombosis in high risk patients. Haemostasis 1975 1.06
10 One-step procedure for the rapid isolation of mouse monoclonal antibodies and their antigen binding fragments by fast protein liquid chromatography on a mono Q anion-exchange column. J Chromatogr 1985 1.03
11 Increase of platelet thromboxane A2 formation and of its plasmatic half-life in diabetes mellitus. Thromb Res 1980 0.99
12 Monoclonal antibodies against platelet membrane glycoproteins. Characterization and effect on platelet function. Eur J Biochem 1983 0.99
13 [Letter: Cholostatic jaundice caused by carbimazole]. Nouv Presse Med 1973 0.97
14 The effect of recombinant factor VIIa (NovoSeven) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0. Blood Coagul Fibrinolysis 1998 0.97
15 Complex formation of human thrombospondin with osteonectin. Eur J Biochem 1988 0.96
16 Anticardiolipin antibodies and giant cell arteritis: a prospective, multicenter case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes. Arthritis Rheum 1998 0.96
17 Thrombocytopenia, macrothrombocytopathia, nephritis and deafness. Am J Med 1976 0.95
18 Identification of human platelet glycoproteins in SDS-polyacrylamide gels using 125I labelled lectins. Thromb Res 1979 0.90
19 Isolation of thrombospondin released from thrombin-stimulated human platelets by fast protein liquid chromatography on an anion-exchange Mono-Q column. J Chromatogr 1984 0.89
20 Inhibition of platelet aggregation and thromboxane synthesis after intake of small amount of icosapentaenoic acid. Thromb Res 1984 0.89
21 Role of lipoxygenase products in platelet function: relation to fatty acid modified phospholipids. Adv Exp Med Biol 1985 0.88
22 Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors. J Thorac Cardiovasc Surg 1993 0.87
23 Platelets and aging. I--Aggregation, arachidonate metabolism and antioxidant status. Thromb Res 1988 0.86
24 Protein-S, a vitamin K-dependent protein, is a bone matrix component synthesized and secreted by osteoblasts. Endocrinology 1992 0.86
25 A comparison of the major platelet membrane glycoproteins from Bernard-Soulier syndrome with normals after radiolabelling of sialic acid or terminal galactose/N-acetylgalactosamine residues. Thromb Res 1980 0.86
26 Antiprothrombinase and factor II deficiency in a non SLE patient. Thromb Haemost 1981 0.86
27 Studies on platelet glycoproteins in Glanzmann's thrombasthenia using 125I-labelled lectins. Br J Haematol 1980 0.86
28 Population pharmacokinetics of recombinant factor VIIa in volunteers anticoagulated with acenocoumarol. Thromb Haemost 1998 0.86
29 Description of 10 new mutations in platelet glycoprotein IIb (alphaIIb) and glycoprotein IIIa (beta3) genes. Platelets 2001 0.84
30 Open trial of intravenous tissue plasminogen activator in acute carotid territory stroke. Correlations of outcome with clinical and radiological data. Stroke 1996 0.84
31 Lipoxygenase activity of intact human platelets. Prostaglandins Leukot Med 1984 0.83
32 Platelet membrane glycoprotein abnormalities in patients with myeloproliferative disorders and secondary thrombocytosis. Br J Haematol 1985 0.83
33 Identification of two distinct regions within the binding sites for fibrinogen and fibronectin on the IIb-IIIa human platelet membrane glycoprotein complex by monoclonal antibodies P2 and P4. Eur J Biochem 1986 0.82
34 Inhibition of thrombin-induced platelet arachidonic acid release by 15-hydroperoxy-arachidonic acid. Biochem Biophys Res Commun 1981 0.81
35 Constitutional thrombocytopathy with subnormal response to thromboxane A2. Br J Haematol 1981 0.81
36 Prostaglandin E2-like activity of 20:3n-9 platelet lipoxygenase end-product. FEBS Lett 1985 0.81
37 Comparative evaluation of plasma thrombospondin beta-thromboglobulin and platelet factor 4 in acute myocardial infarction. Thromb Res 1985 0.81
38 Polyunsaturated fatty acids: drug or food? World Rev Nutr Diet 1984 0.81
39 Platelet-aggregation inhibition and hemodynamic effects of beraprost sodium, a new oral prostacyclin derivative: a study in healthy male subjects. Can J Physiol Pharmacol 1996 0.81
40 Two novel fibrinogen variants found in patients with pulmonary embolism and their families. J Thromb Haemost 2003 0.81
41 Impairment of platelet thromboxane A2 generation and of the platelet release reaction in two patients with congenital deficiency of platelet cyclo-oxygenase. Br J Haematol 1978 0.80
42 Antithrombin III deficiency during continuous venovenous hemodialysis. Contrib Nephrol 1995 0.80
43 In vitro incorporation and metabolism of some icosaenoic acids in platelets. Effect on arachidonic acid oxygenation. Biochim Biophys Acta 1985 0.79
44 Nicergoline, an anti-aggregating agent which inhibits release of arachidonic acid from human platelet phospholipids. Prostaglandins 1980 0.79
45 A comparison of techniques used to study externally oriented proteins and glycoproteins of human blood platelets. Thromb Res 1979 0.79
46 Osteonectin is an alpha-granule component involved with thrombospondin in platelet aggregation. J Bone Miner Res 1991 0.79
47 Expression of adhesion molecules in endothelial cells during allogeneic bone marrow transplantation. Eur J Haematol 1994 0.79
48 Thalamic stroke and congenital factor V deficiency. Stroke 1991 0.79
49 Platelet phospholipid in stroke. Clin Chim Acta 1978 0.79
50 Tryptic peptide map analysis of the major human blood platelet membrane glycoproteins separated by two-dimensional polyacrylamide gel electrophoresis. Biochim Biophys Acta 1982 0.79
51 [Fibrinolytic activity of platelets]. Nouv Presse Med 1973 0.78
52 Effects of ticlopidine on platelet prostaglandin metabolism. Possible consequences for prostacyclin production. Prostaglandins Med 1979 0.78
53 Factor IX gene analysis in 70 unrelated patients with haemophilia B: description of 13 new mutations. Thromb Haemost 1999 0.78
54 Increase of platelet prostaglandin cyclic endoperoxides in thrombosis. Lancet 1977 0.78
55 Illegitimate transcription: its use for studying genetic abnormalities in lymphoblastoid cells from patients with Glanzmann thrombasthenia. Br J Haematol 1998 0.78
56 Identification of new and known polymorphisms in glycoprotein IIb and IIIa genes by denaturing gradient gel electrophoresis. Platelets 1998 0.78
57 Immunofluorescence study of mucosal B lymphocytes in bile reflux gastritis. Digestion 1979 0.78
58 Identification and characterization of fragments of major glycoproteins from platelet membrane after chymotrypsin treatment. Eur J Biochem 1985 0.78
59 Tandem separation of labelled human blood platelet membrane glycoproteins by anion-exchange and gel fast protein liquid chromatography. J Chromatogr 1985 0.78
60 Increased thrombosis incidence in a family with an inherited protein S deficiency and a high oxygen affinity hemoglobin variant. Am J Hematol 1994 0.78
61 Human plasma fibrinogen measurement derived from activated partial thromboplastin time clot formation. Blood Coagul Fibrinolysis 2002 0.78
62 Decrease of platelet activity after intake of small amounts of eicosapentaenoic acid in diabetics. Thromb Haemost 1982 0.78
63 [Severe viral hepatitis. Intravascular coagulation and fibrinolysis. Radioisotopic study of the life of platelets and fibrinogens]. Presse Med 1971 0.78
64 Aggregation to thrombin and collagen of platelets from a Glanzmann thrombasthenic patient lacking glycoproteins IIb and IIIa. Thromb Haemost 1989 0.78
65 Significant reduction in the binding of a monoclonal antibody (LYP 18) directed against the IIb/IIIa glycoprotein complex to platelets of patients having undergone extracorporeal circulation. Thromb Haemost 1987 0.77
66 Uptake and effect on arachidonic acid oxygenation of some icosaenoic acids in human platelets. Biomed Biochim Acta 1984 0.77
67 Human platelet PGE1 and dihomogammalinolenic acid. Comparison to PGE2 and arachidonic acid. Prog Lipid Res 1981 0.77
68 Thrombin decreases platelet cyclic AMP in the absence of prostaglandin synthesis. Biomedicine 1977 0.77
69 Simultaneous enzymo-immunologic assays of platelet associated IgG, IgM and C3. A useful tool in assessment of immune thrombocytopenias. Thromb Res 1982 0.77
70 Evaluation of coagulation equilibrium at baseline and during factor VIII and factor IX replacement in haemophiliacs. Blood Coagul Fibrinolysis 1998 0.77
71 Refractoriness of diabetic platelets to inhibitory prostaglandins. Prostaglandins Med 1981 0.77
72 [Alterations in hemostasis during treatment with sodium dipropylacetate (Depakine) (R)]. Pediatrie 1979 0.77
73 Fatty acid composition in native and cultured human endothelial cells. In Vitro 1984 0.76
74 Thrombomodulin is synthesized by osteoblasts, stimulated by 1,25-(OH)2D3 and activates protein C at their cell membrane. Endocrinology 1993 0.76
75 Efficacy and safety of continuous infusion of Mononine during five surgical procedures in three hemophilic patients. Am J Hematol 1998 0.76
76 Molecular study of Glanzmann thrombasthenia in 3 patients issued from 2 different families. Thromb Haemost 1995 0.76
77 Acute myocardial infarction: measurement of arachidonate end-products in whole blood as an index of platelet cyclo-oxygenase activity in vivo. Thromb Res 1987 0.76
78 Metabolism of human monoclonal immunoglobulin D. A study in two patients with monoclonal IgD gammapathy. Biomedicine 1974 0.76
79 Functions and tocopherol content of blood platelets from elderly people after low intake of purified eicosapentaenoic acid. Thromb Res 1990 0.76
80 Results of splenectomy for idiopathic thrombocytopenic purpura. Review of 72 cases. Acta Haematol 1993 0.76
81 Pharmacokinetic studies of standard heparin and low molecular weight heparin in patients with chronic renal failure. Haemostasis 1986 0.76
82 Dose-response studies of platelet aggregation and bleeding time during eicosapentaenoic acid intake. Thromb Haemost 1991 0.76
83 Intravenous plasmin-treated gammaglobulin therapy in idiopathic thrombocytopenic purpura. Results in 40 patients. Nouv Rev Fr Hematol 1985 0.75
84 [Calcium 47 absorption in alcoholic cirrhosis. Effect of 25 hydroxycholecalciferol]. Nouv Presse Med 1975 0.75
85 Different utilization of arachidonic and dihomogammalinolenic acids by human platelet prostaglandin synthetase. Biochimie 1977 0.75
86 [Analgesic effect and fecal blood loss induced by antrafenine. A double-blind comparison with aspirin]. Rev Rhum Mal Osteoartic 1981 0.75
87 A simple radiochemical assay of thromboxane B2, 12-hydroxyeicosatetraenoic acid (HETE) and 12-hydroxyheptadecatrienoic acid (HHT) synthetized by human platelets. Clin Chim Acta 1977 0.75
88 [A case of primary hyperaldosteronism. Considerations on the diagnostic and therapeutic levels]. Lyon Med 1969 0.75
89 Increased plasma free gamma carboxyglutamic acid levels during deep vein thrombosis and intravascular disseminated coagulation. Thromb Res 1994 0.75
90 Drugs effect on platelet survival time: comparison of two pyrimido-pyrimidine derivatives in patients with aortic or mitral replacement. Thromb Haemost 1984 0.75
91 Increased thrombin generation in a child with a combined factor IX and protein C deficiency. Blood 1993 0.75
92 [Development of drug-induced acute neutropenia and granulocyte kinetics]. Lyon Med 1972 0.75
93 Plasma lipoproteins and fatty acid composition after "minipill". Contraception 1983 0.75
94 Physiological relevance of the formation of 15-hydroxy derivative from dihomogammalinolenic acid in human platelets. Prog Clin Biol Res 1987 0.75
95 A nonsense mutation in the GPIIb heavy chain (Ser 870-->stop) impairs platelet GPIIb-IIIa expression. Br J Haematol 1996 0.75
96 Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions. Thromb Res 1984 0.75
97 Plasma thrombospondin in patients with chronic renal failure, liver disease and splenectomy. Thromb Res 1985 0.75
98 [IgM kappa gastric plasmacytoma]. Gastroenterol Clin Biol 1989 0.75
99 [Gluten intolerance in the adult (apropos of 15 cases)]. Lyon Med 1971 0.75
100 Collagen stimulates more platelet prostaglandin endoperoxides in thrombosis. Biomedicine 1977 0.75
101 Safety and efficacy of three arthroscopic procedures using Holmium: Yag laser in two high-responder haemophiliacs. Haemophilia 1999 0.75
102 [Therapeutic evolution of 63 cases of recent acute myeloblastic leukemias]. Lyon Med 1971 0.75
103 Platelet phospholipids in venous thrombosis after surgical operation. Biochem Med 1977 0.75
104 [Cytology of the esophagus by endoscopic brushing: value in the diagnosis of gastro-esophageal reflux]. Arch Anat Cytol Pathol 1988 0.75
105 [High doses of methotrexate followed by folinic acid in acute leukemia and solid tumors]. Lyon Med 1970 0.75
106 [Comparative study of the ultrastructure and excretion induced by thrombin of washed platelets prepared from blood samples conserved on EDTA and acidified ACD]. Pathol Biol (Paris) 1973 0.75
107 Fatty acids bound to serumalbumin decrease the half-life of thromboxane A2. Prostaglandins 1980 0.75
108 [Primary hemostasis]. Lyon Med 1972 0.75
109 [Demonstration of 2 compartments of cyclic AMP in suspensions of human platelets]. Pathol Biol (Paris) 1974 0.75
110 48740 RP, an antagonist of PAF, does not affect human plasma fibrinolysis before and after venous occlusion. Thromb Res 1988 0.75
111 [Letter: Rise in blood levels in uric acid and of lacticodehydrogenase, cellular lysis, and aggraviation of certain hemopathies]. Nouv Presse Med 1974 0.75
112 [Blood platelet cyclic AMP and prostaglandin E1 before and during post-operative venous thrombosis]. Biomedicine 1975 0.75
113 Successful arthroscopic synovectomy using holmium: Yag laser and FEIBA in a high responder hemophiliac. Am J Hematol 1993 0.75
114 [Asparaginase in acute leukemia]. Lyon Med 1970 0.75
115 [Indications for splenectomy in the anemic forms of myelofibrosis with myeloid metaplasia of the spleen]. Sem Hop 1972 0.75
116 [Comparative study of acetylsalicylic acid and calcium heparinate in the prevention of venous thrombosis after transurethral resection of the prostate]. Agressologie 1983 0.75
117 Quantitative immunochemistry of endothelial cells in cutaneous tissue. Anal Cell Pathol 1995 0.75
118 Effects of gliclazide, a new antidiabetic agent, on the platelet release reaction, role of adenylate cyclase. Thromb Res 1975 0.75
119 [Antiplatelet drugs (author's transl)]. Anesth Analg (Paris) 1979 0.75
120 [Lupus anticoagulant screening: comparison of 5 tests (author's transl)]. Nouv Rev Fr Hematol 1981 0.75
121 [Myelomatous globulins]. Rev Lyon Med 1968 0.75
122 [Platelet abnormalities during diabetes mellitus]. Sem Hop Ther 1974 0.75
123 [Radioisotope study of erythropoiesis and hemolysis in myelofibrosis with myeloid metaplasia of the spleen. Its value in splenectomy indications]. Lyon Med 1972 0.75
124 [The radioimmunological assay of fibrinogen breakdown products with E antigen during postoperative venous thromboses. Study in 46 cases of arthroplasty for osteoarthrosis of the hip (author's transl)]. Nouv Presse Med 1977 0.75
125 [Isotopic exploration of erythropoiesis in chronic lymphoid leukemia]. Nouv Rev Fr Hematol 1972 0.75
126 Comparative plasma heparin levels after subcutaneous administration of calcium and magnesium heparin. Thromb Res 1982 0.75
127 Increased in vivo biosynthesis of prostacyclin and thromboxane A2 in chronic idiopathic thrombocytopenic purpura. Br J Haematol 1989 0.75
128 Basal level of human platelet prostaglandins: PGE1 is more elevated than PGE2. Prostaglandins 1979 0.75
129 Combined factor IX and protein C deficiency in a child: thrombogenic effects of two factor IX concentrates. Am J Hematol 1995 0.75
130 Platelet prostaglandins and related compounds in diabetes mellitus. Adv Exp Med Biol 1984 0.75
131 Intravenous high-dose IgG therapy induced alterations of spleen lymphocyte IgM secretion and T cell subsets in patients with idiopathic thrombocytopenic purpura. Thromb Res 1987 0.75
132 Substitution of cysteine for phenylalanine 751 in mature von Willebrand factor is a novel candidate mutation in a family with type IIA von Willebrand disease. Br J Haematol 1993 0.75
133 [Effects of lysine-vasopressin on blood cortisol levels. Practical implications]. Rev Fr Endocrinol Clin 1972 0.75
134 [Low molecular weight heparin in the surgery of total hip prosthesis in 1994]. Ann Fr Anesth Reanim 1994 0.75
135 [Stereological analysis of the degranulation and the contraction of platelets. Application to the ultrastructural study of thrombin induced excretion in vitro]. Pathol Biol (Paris) 1975 0.75
136 [Bibliographic note: serotonin and normal platelets in adult man]. Lyon Med 1970 0.75
137 [Human platelet antiplasmin. Detection and determination of a noncompetitive inhibitor effect of plasmin using a technic with radiofibrinogen]. Pathol Biol (Paris) 1973 0.75
138 Effects of linoleic acid and gamma-linolenic acid intake on platelet functions in elderly people. Thromb Res 1986 0.75
139 Comparison of hemostasis with two high-flux hemocompatible dialysis membranes. Int J Artif Organs 1991 0.75
140 Increased plasma tissue-type plasminogen activator levels in patients with chronic thrombocytopenia. Haemostasis 1990 0.75
141 [Platelet chloroquine and serotonin. Demonstration of competitive inhibition of serotonin uptake]. Experientia 1975 0.75
142 [Effect of gliclazide on platelet behavior]. Nouv Presse Med 1974 0.75
143 [Erythrokinetics in hemolysis caused by heart valve prosthesis. Apropos of 4 cases]. Presse Med 1970 0.75
144 Decreased factor XII activity in a child with nephrotic syndrome and thromboembolic complications. Thromb Haemost 1991 0.75
145 [Biclonal gammapathy. (Apropos of the isotopic study of a case observed in myeloma)]. Rev Rhum Mal Osteoartic 1972 0.75
146 Potentiating effect of 5,8,11-eicosatrienoic acid on human platelet aggregation. Lipids 1983 0.75
147 [Reliability of the radioactive fibrinogen test for the detection of venous thrombosis following total hip prosthesis]. Rev Chir Orthop Reparatrice Appar Mot 1978 0.75
148 Pentosan polysulphate associated thrombocytopenia. Thromb Res 1986 0.75
149 [Gamma-D monoclonal gammopathy with medullary plasmocyte infiltration in polyglobulia of the Vaquez type. Determination of the biological period]. Nouv Rev Fr Hematol 1972 0.75
150 [Platelet prostaglandins and apparent components in diabetes mellitus]. Nouv Rev Fr Hematol 1982 0.75
151 Priming effect of adrenic acid (22:4(n-6)) on tissue factor activity expressed by thrombin-stimulated endothelial cells. Atherosclerosis 1992 0.75
152 [Study of the kinetics of platelets and fibrinogen by radioisotopic labelling in splenomegalic cirrhosis with thrombopenia]. Pathol Biol (Paris) 1972 0.75
153 Dihomogammalinolenic acid (20:3 omega 6) is more anti-aggregatory than eicosapentaenoic (20:5 omega 3) in a platelet-endothelial cell mixture. Prostaglandins Med 1980 0.75
154 [In vitro demonstration of anti-platelet antibodies during idiopathic thrombocytopenic purpura by measurement of platelet 14C-serotonin release]. Pathol Biol (Paris) 1974 0.75
155 [Study of platelet kinetics by labelling with chromium 51 in normal human adults]. Lyon Med 1970 0.75
156 Increased lipid peroxidation in platelets from elderly people. Thromb Haemost 1985 0.75
157 [Inefficient erythropoiesis: apropos of 49 cases diagnosed by the radioisotope method]. Nouv Rev Fr Hematol 1973 0.75
158 Successful treatment of acquired factor VIII antibody by extracorporeal immunoadsorption. Acta Haematol 1991 0.75
159 [Statistical study of serum immunoglobulin levels in burned patients]. Anesth Analg (Paris) 1975 0.75
160 [Letter: Detection of antiplatelet auto- and allo-antibodies by measure of excretion and platelet aggregation. Value of the diagnosis of idiopathic thrombopenic purpura]. Nouv Presse Med 1973 0.75
161 [Sterologic evaluation on in vitro thrombin-induced platelet degranulation and contraction (author's transl)]. Nouv Rev Fr Hematol 1978 0.75
162 [Study of the in-vitro degranulation of blood platelets with a quantitative ultrastructural method]. C R Seances Soc Biol Fil 1972 0.75
163 [Rapid preparation of human fibrinogen labelled with iodine 125]. Pathol Biol (Paris) 1971 0.75
164 [Infusion of human immunoglobulins in idiopathic thrombopenic purpura. Experience in 37 patients]. Presse Med 1983 0.75
165 [Prophylaxis of thromboembolic disease in a surgical milieu]. Therapie 1978 0.75
166 [Therapeutic course of 30 recent cases of acute lymphoblastic leukemia]. Lyon Med 1971 0.75
167 [Prevention of venous thrombosis. Success of high doses of heparin during total hip replacement for osteoarthritis]. Nouv Presse Med 1974 0.75
168 Post-surgical deep vein thrombosis in woman with congenital platelet cyclo-oxygenase deficiency. Br J Haematol 1978 0.75
169 [Diagnosis of venous thrombosis and/or pulmonary embolism by determination of d-dimers using ELISA. Review based on a study of 80 consecutive patients hospitalized in an emergency unit]. J Mal Vasc 1996 0.75
170 [The value of cytology in the diagnosis of herpetic esophagitis. Apropos of 2 case reports]. Ann Gastroenterol Hepatol (Paris) 1985 0.75
171 [Laxative disease]. J Med Lyon 1971 0.75
172 [Functional exclusion of the spleen in drepanocytosis. Isotope diagnosis]. Lyon Med 1972 0.75
173 An unusual haemarthrosis in an HIV-seronegative haemophilia A patient. Haemophilia 1998 0.75
174 [Niflumic acid in rheumatology]. Rev Lyon Med 1970 0.75
175 Amegakaryocytic thrombocytopenic purpura treated with antithymocyte globulin. Ann Intern Med 1985 0.75
176 [Acute kidney failure caused by hypokaliemia. Disease of laxatives]. Lyon Med 1970 0.75
177 [Platelets and vanous thrombosis]. Nouv Presse Med 1974 0.75
178 [A compative study of electro-immunodiffusion and radial immunodiffusion with application to the determination of immunoglobulins]. Pathol Biol (Paris) 1974 0.75
179 [On the utility of a psycho-analeptic drug in general pathology]. Lyon Med 1966 0.75
180 [Influence of diet and life habits on platelet functions]. Rev Prat 1989 0.75
181 [Thrombocytopathia with cyclo-oxygenase deficiency]. Nouv Rev Fr Hematol 1976 0.75
182 [Sodium valproate and changes in hemostasis]. Nouv Presse Med 1982 0.75
183 [Protein C deficiency: recurrent extensive phlebitis during the transfer from heparin to antivitamin K]. Presse Med 1985 0.75
184 [A case of arteriovenous fistula in thyroid cancer]. Lyon Med 1971 0.75
185 [Comparison between marrow histology and radioactive iron metabolism in marrow insufficiency and prognostic value of this last examination]. Nouv Rev Fr Hematol 1970 0.75
186 [Cystic ovarian reaction during a HMG-HCG therapy for ante-pubertal Stein-Leventhal syndrome]. Rev Lyon Med 1970 0.75